Cystic Fibrosis
NICE’s Rejection of Trikafta May Signal Price Dispute with Vertex in the UK
Anika Sharma
Vertex Pharmaceuticals faces a potential reiteration of history in the United Kingdom, where a recent decision by the National Institute ...
Vertex partners with Septerna to develop GPCR-targeting drugs for rare diseases
Anika Sharma
Septerna, a biotech company, has secured an additional $47.5 million in funding through a licensing agreement with Vertex, a prominent ...
First Wave BioPharma’s Pancreatic Enzyme Replacement Therapy Faces Hurdles, Stock Plummets
SG Tylor
Source – First Wave BioPharma First Wave BioPharma, formerly known as AzurRx BioPharma, has faced ongoing challenges in bringing a ...
European Commission Grants Approval for ORKAMBI to Treat Cystic Fibrosis in Children Aged 1 to <2 Years
SG Tylor
Source – Vertex Pharmaceuticals On July 5, 2023, Vertex Pharmaceuticals announced that the European Commission has granted approval for the ...
